These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10483609)

  • 1. Oligonucleotide delivery: a cellular prospective.
    Liang E; Ajmani PS; Hughes JA
    Pharmazie; 1999 Aug; 54(8):559-66. PubMed ID: 10483609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligonucleotide delivery to tumours using macromolecular carriers.
    Dass CR
    Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):113-22. PubMed ID: 15070400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NFkappaB decoy oligonucleotides.
    De Stefano D; De Rosa G; Carnuccio R
    Curr Opin Mol Ther; 2010 Apr; 12(2):203-13. PubMed ID: 20373264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the human genome.
    Tachikawa K; Briggs SP
    Curr Opin Biotechnol; 2006 Dec; 17(6):659-65. PubMed ID: 17085035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of hepatic genomic DNA using RNA/DNA oligonucleotides.
    Kren BT; Chen Z; Felsheim R; Roy Chowdhury N; Roy Chowdhury J; Steer CJ
    Gene Ther; 2002 Jun; 9(11):686-90. PubMed ID: 12032688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FRET-FCS as a tool to evaluate the stability of oligonucleotide drugs after intracellular delivery.
    Remaut K; Lucas B; Braeckmans K; Sanders NN; De Smedt SC; Demeester J
    J Control Release; 2005 Mar; 103(1):259-71. PubMed ID: 15710516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted correction of a chromosomal point mutation by modified single-stranded oligonucleotides in a GFP recovery system.
    Yin WX; Wu XS; Liu G; Li ZH; Watt RM; Huang JD; Liu DP; Liang CC
    Biochem Biophys Res Commun; 2005 Sep; 334(4):1032-41. PubMed ID: 16039616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of polyplexes: toward synthetic virus vector systems.
    Wagner E; Culmsee C; Boeckle S
    Adv Genet; 2005; 53():333-54. PubMed ID: 16241000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-phase synthesis of oligonucleotide conjugates useful for delivery and targeting of potential nucleic acid therapeutics.
    Lönnberg H
    Bioconjug Chem; 2009 Jun; 20(6):1065-94. PubMed ID: 19175328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycation gene delivery systems: escape from endosomes to cytosol.
    Cho YW; Kim JD; Park K
    J Pharm Pharmacol; 2003 Jun; 55(6):721-34. PubMed ID: 12841931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides.
    Remaut K; Lucas B; Braeckmans K; Demeester J; De Smedt SC
    J Control Release; 2007 Feb; 117(2):256-66. PubMed ID: 17188777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted gene repair in mammalian cells using chimeric RNA/DNA oligonucleotides and modified single-stranded vectors.
    Parekh-Olmedo H; Czymmek K; Kmiec EB
    Sci STKE; 2001 Mar; 2001(73):pl1. PubMed ID: 11752645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in oligonucleotide conjugation.
    Singh Y; Murat P; Defrancq E
    Chem Soc Rev; 2010 Jun; 39(6):2054-70. PubMed ID: 20393645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of oligonucleotides for therapeutic applications.
    Fichou Y; Férec C
    Trends Biotechnol; 2006 Dec; 24(12):563-70. PubMed ID: 17045686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted gene correction strategies.
    Richardson PD; Kren BT; Steer CJ
    Curr Opin Mol Ther; 2001 Aug; 3(4):327-37. PubMed ID: 11525556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photochemical drug and gene delivery.
    Berg K; Selbo PK; Prasmickaite L; Høgset A
    Curr Opin Mol Ther; 2004 Jun; 6(3):279-87. PubMed ID: 15264430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide nanoparticles for oligonucleotide delivery.
    Lehto T; Ezzat K; Langel U
    Prog Mol Biol Transl Sci; 2011; 104():397-426. PubMed ID: 22093225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligonucleotide delivery in cancer therapy.
    De Rosa G; De Stefano D; Galeone A
    Expert Opin Drug Deliv; 2010 Nov; 7(11):1263-78. PubMed ID: 20977291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene targeting for gene therapy: prospects.
    Lanzov VA
    Mol Genet Metab; 1999 Oct; 68(2):276-82. PubMed ID: 10527679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.